TROPHY-U-01: Sacituzumab Govitecan for Platinum-ineligible Metastatic UC

By Daniel P. Petrylak, MD - Last Updated: February 18, 2023

Daniel P. Petrylak, MD, a Professor of Medicine and Urology at the Yale School of Medicine, overviews the TROPHY-U-01 study for platinum-ineligible patients with metastatic urothelial carcinoma who have progressed on checkpoint inhibitor therapy.

Post Tags:ASCO GU 2023-Bladder Cancer
Advertisement
Advertisement